Flanagan Joseph Gerard
Chief Executive Officer at RCM; President and CEO at Accretive Health, Inc.; (1) See Remarks at NORTEL NETWORKS CORP
- Sold, on record
- $35.1M
- Dollars the filings state
- Form 4 sales
- 7
- Latest Aug 18, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- RCMR1 RCM Inc. /DEChief Executive Officer
- Accretive Health, Inc.President and CEO
- NORTEL NETWORKS CORP(1) See Remarks
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Accretive Health, Inc.869,931 shares
- RCM600,000 shares
- NORTEL NETWORKS CORP1,074 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale NORTEL NETWORKS CORPPlan not statedMar 27, 2008 2008
Sold 345 shares at $6.59 ($2k)
Flanagan Joseph Gerard, (1) See Remarks
Sold 12.1% of holdings ($19k position)2,505 shares leftFirst sale on recordFiling
- 2 Form 4 sale NORTEL NETWORKS CORPPlan not statedJun 17, 2008 +82 days
Sold 442 shares at $10.14 ($4k)
Flanagan Joseph Gerard, (1) See Remarks
Sold 13.3% of holdings ($34k position)2,892 shares leftFiling
- 3 Form 4 sale NORTEL NETWORKS CORPPlan not statedNov 11, 2008 +147 days
Sold 287 shares at $0.95 ($273)
Flanagan Joseph Gerard, (1) See Remarks
Sold 12.8% of holdings ($2k position)1,963 shares leftFiling
- 4 Form 4 sale Accretive Health, Inc.Plan not statedJun 1, 2021 +4585 days
Sold 500,000 shares at $21.83 ($10.9M)
Flanagan Joseph Gerard, President and CEO
Sold 16.8% of holdings ($65.1M position)2.5M shares leftFirst sale on recordFiling
- 5 Form 4 sale Accretive Health, Inc.Plan not statedOct 14, 2021 +135 days
Sold 130,517 shares at $23.11 ($3M)
Flanagan Joseph Gerard, President and CEO
Sold 4.9% of holdings ($61M position)2.5M shares leftFiling
- 6 Form 4 sale Accretive Health, Inc.Plan not statedNov 11, 2021 +28 days
Sold 239,414 shares at $25.48 ($6.1M)
Flanagan Joseph Gerard, President and CEO
Sold 8.7% of holdings ($70.1M position)2.5M shares leftFiling
- 7 Form 4 sale RCMPlan not statedAug 18, 2022 +280 days
Sold 600,000 shares at $25.06 ($15M)
Flanagan Joseph Gerard, Chief Executive Officer
Sold 17.7% of holdings ($85M position)2.8M shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (7)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2022 | Aug 18, 2022 | RCM | Chief Executive Officer | Form 4 sale | 600,000 | $15M | 17.7% | Plan not stated | SEC |
| Nov 11, 2021 | Nov 12, 2021 | Accretive Health, Inc. | President and CEO | Form 4 sale | 239,414 | $6.1M | 8.7% | Plan not stated | SEC |
| Oct 14, 2021 | Oct 14, 2021 | Accretive Health, Inc. | President and CEO | Form 4 sale | 130,517 | $3M | 4.9% | Plan not stated | SEC |
| Jun 1, 2021 | Jun 2, 2021 | Accretive Health, Inc. | President and CEO | Form 4 sale | 500,000 | $10.9M | 16.8% | Plan not stated | SEC |
| Nov 11, 2008 | Nov 12, 2008 | NORTEL NETWORKS CORP | (1) See Remarks | Form 4 sale | 287 | $273 | 12.8% | Plan not stated | SEC |
| Jun 17, 2008 | Jun 18, 2008 | NORTEL NETWORKS CORP | (1) See Remarks | Form 4 sale | 442 | $4k | 13.3% | Plan not stated | SEC |
| Mar 27, 2008 | Mar 31, 2008 | NORTEL NETWORKS CORP | (1) See Remarks | Form 4 sale | 345 | $2k | 12.1% | Plan not stated | SEC |